Home
AMPH
AMPH News

Latest Amphastar Pharmaceuticals Inc. (AMPH) News on September 18, 2025

A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Pack

StockStory

13 days ago

A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Pack

Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q1 Earnings?

StockStory

3 months ago

Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q1 Earnings?

Argus Research

3 months ago

AMPH: Rating decreased to a HOLD

3 Value Stocks with Questionable Fundamentals

StockStory

3 months ago

3 Value Stocks with Questionable Fundamentals

AMPH Q1 Earnings Call: Product Mix Shift and Margin Pressures Highlight Competitive Challenges

StockStory

3 months ago

AMPH Q1 Earnings Call: Product Mix Shift and Margin Pressures Highlight Competitive Challenges

3 Russell 2000 Stocks with Questionable Fundamentals

StockStory

3 months ago

3 Russell 2000 Stocks with Questionable Fundamentals

3 Small-Cap Stocks Walking a Fine Line

StockStory

4 months ago

3 Small-Cap Stocks Walking a Fine Line

Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know

StockStory

4 months ago

Evolent Health, Amphastar Pharmaceuticals, Iridium, and Magnite Stocks Trade Up, What You Need To Know

Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers

StockStory

4 months ago

Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

ACCESS Newswire

4 months ago

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Argus Research

4 months ago

AMPH: Raising target price to $28.00

Argus Research

4 months ago

AMPH: What does Argus have to say about AMPH?

MT Newswires

4 months ago

JPMorgan Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $30 From $45

Amphastar Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations

Simply Wall St.

4 months ago

Amphastar Pharmaceuticals First Quarter 2025 Earnings: Misses Expectations

Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference

ACCESS Newswire

4 months ago

Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Amphastar Pharmaceuticals Inc Earnings Call

Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics

Zacks

4 months ago

Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 Sales Targets

StockStory

4 months ago

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 Sales Targets

Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates

Zacks

4 months ago

Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates

Associated Press Finance

4 months ago

Amphastar: Q1 Earnings Snapshot

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

ACCESS Newswire

4 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Argus Research

4 months ago

AMPH: Lowering target price to $26.00

Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect

StockStory

4 months ago

Amphastar Pharmaceuticals (AMPH) Reports Earnings Tomorrow: What To Expect

Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock?

Zacks

5 months ago

Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock?

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

ACCESS Newswire

5 months ago

Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025

2 Safe-and-Steady Stocks with Solid Fundamentals and 1 to Think Twice About

StockStory

5 months ago

2 Safe-and-Steady Stocks with Solid Fundamentals and 1 to Think Twice About

Argus Research

5 months ago

AMPH: What does Argus have to say about AMPH?

MT Newswires

5 months ago

BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36

Argus Research

5 months ago

AMPH: What does Argus have to say about AMPH?

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth?

Insider Monkey

5 months ago

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth?

2 Reasons to Like AMPH and 1 to Stay Skeptical

StockStory

5 months ago

2 Reasons to Like AMPH and 1 to Stay Skeptical

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Simply Wall St.

5 months ago

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Argus Research

5 months ago

AMPH: Lowering target price to $26.00

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

ACCESS Newswire

5 months ago

Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

Argus Research

6 months ago

AMPH: What does Argus have to say about AMPH?

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

ACCESS Newswire

6 months ago

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

Argus Research

6 months ago

AMPH: Raising target price to $31.00

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory

6 months ago

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

ACCESS Newswire

6 months ago

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory

6 months ago

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

Argus Research

6 months ago

AMPH: Lowering target price to $29.00

Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

7 months ago

Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey

7 months ago

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now?

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds

Benzinga

7 months ago

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds

GuruFocus.com

7 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q4 2024 Earnings Call Highlights: Revenue Growth and ...

Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

7 months ago

Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

Zacks

7 months ago

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

Associated Press Finance

7 months ago

Amphastar: Q4 Earnings Snapshot

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%

StockStory

7 months ago

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%

Amphastar Pharmaceuticals' (NASDAQ:AMPH) 15% CAGR outpaced the company's earnings growth over the same five-year period

Simply Wall St.

7 months ago

Amphastar Pharmaceuticals' (NASDAQ:AMPH) 15% CAGR outpaced the company's earnings growth over the same five-year period

Earnings To Watch: Amphastar Pharmaceuticals (AMPH) Reports Q4 Results Tomorrow

StockStory

7 months ago

Earnings To Watch: Amphastar Pharmaceuticals (AMPH) Reports Q4 Results Tomorrow

GuruFocus.com

7 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q4 2024 Earnings Report Preview: What To Look For

Argus Research

7 months ago

AMPH: Raising target price to $34.00

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

StockStory

7 months ago

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

ACCESS Newswire

7 months ago

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

StockStory

7 months ago

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

Argus Research

7 months ago

AMPH: Lowering target price to $32.00

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

StockStory

7 months ago

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

StockStory

7 months ago

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

Argus Research

7 months ago

AMPH: Lowering target price to $35.00

MT Newswires

7 months ago

Piper Sandler Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $36 From $66

MT Newswires

7 months ago

BofA Adjusts Price Target on Amphastar Pharmaceuticals to $44 From $46

Argus Research

8 months ago

AMPH: Raising target price to $39.00

Argus Research

8 months ago

AMPH: Lowering target price to $38.00

Argus Research

8 months ago

AMPH: Raising target price to $40.00

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

ACCESSWIRE

8 months ago

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Argus Research

9 months ago

AMPH: Lowering target price to $41.00

Argus Research

9 months ago

AMPH: Lowering target price to $43.00

MT Newswires

9 months ago

Amphastar Pharmaceuticals Insider Sold Shares Worth $672,815, According to a Recent SEC Filing

Argus Research

9 months ago

AMPH: Lowering target price to $46.00

Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?

Simply Wall St.

9 months ago

Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?

Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options

Zacks

9 months ago

Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options

Argus Research

9 months ago

AMPH: Raising target price to $47.00

Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Insider Monkey

10 months ago

Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Argus Research

10 months ago

AMPH: What does Argus have to say about AMPH?

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

ACCESSWIRE

10 months ago

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

Amphastar initiated with an Equal Weight at Wells Fargo

TipRanks

10 months ago

Amphastar initiated with an Equal Weight at Wells Fargo

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

ACCESSWIRE

10 months ago

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

Argus Research

10 months ago

AMPH: Lowering target price to $50.00

Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

10 months ago

Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

Thomson Reuters StreetEvents

10 months ago

Q3 2024 Amphastar Pharmaceuticals Inc Earnings Call

GuruFocus.com

10 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ...

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings

Zacks

10 months ago

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings

Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates

Zacks

10 months ago

Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates

Associated Press Finance

10 months ago

Amphastar: Q3 Earnings Snapshot

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

ACCESSWIRE

10 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

Argus Research

10 months ago

AMPH: What does Argus have to say about AMPH?

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect

GuruFocus.com

10 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zacks

a year ago

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

a year ago

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

ACCESSWIRE

a year ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Zacks

a year ago

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report?

Zacks

a year ago

Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report?

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?

Simply Wall St.

a year ago

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Insider Monkey

a year ago

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Argus Research

a year ago

AMPH: Lowering target price to $49.00

Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options

Zacks

a year ago

Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options

Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns

Simply Wall St.

a year ago

Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

GuruFocus.com

a year ago

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

ACCESSWIRE

a year ago

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

Share on Social Networks: